-
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-upIqbal J, Zhang YJ, Serruys PW et al. -
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES TrialM Szarek, HD White, PH Steg, ODYSSEY OUTCOMES Committees and Investigators.
-
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE TrialDJ Maron, GBJ Mancini, COURAGE Trial Group et al.
-
Potential protective mechanisms of green tea polyphenol EGCG against COVID-19Y Zhang, B Wernly, ZCh Zhou et al.
-
Qualitative and Mixed Methods Provide Unique Contributions to Outcomes ResearchCurry LA, Nembhard IM, Bradley EH.
-
Limitations of Repeat Revascularization as an Outcome MeasureP Lamelas, J Belardi, R Whitlock et al.
-
Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-centerE Oosterwerff, A Adiyaman, A Elvan et al.
-
Poor R-wave progression as a predictor of sudden cardiac death in general population and subjects with coronary artery diseaseLC Schröder, A Holkeri, A Eranti et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
